Last $32.01 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 02/20/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Helmut Kraft

Chief Financial Officer and Member of Executive Board, Stada-Arzneimittel AG
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 4 different industries.

See Board Relationships
55€1,470,504
As of Fiscal Year 2013

Background*

Mr. Helmut Kraft has been the Chief Financial Officer and Member of Executive Board at Stada-Arzneimittel AG since January 1, 2010. A trained attorney, Mr. Kraft served as Head of Group Finance, Taxes and Investments at the PHOENIX group, a leading European pharmaceutical wholesaler, since 1996. He served at Landis & Gyr Holding GmbH (Siemens Building Technologies) as Head of Finance and Taxes from 1996 to 2009 and at KPMG Deutsche Treuhand-Gesellschaft, Aktiengesellschaft, ...

Read Full Background

Corporate Headquarters*

Stadastrasse 2-18
Bad Vilbel, -- 61118

Germany

Phone: 49 6101 6030
Fax: 49 6101 603 259

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education 1987
University of Heidelberg

Other Affiliations*

Annual Compensation*

Salary€750,000
Bonus€686,325
Total Annual Compensation€1,436,325

Stock Options*

All Other Compensation€34,179

Total Compensation*

Total Annual Cash Compensation€1,470,504
Total Short Term Compensation€1,436,325
Other Long Term Compensation€34,179
Total Calculated Compensation€1,470,504
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STDAF:US $32.01 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Pamela Louise Makin MA, Ph.D., MBAChief Executive Officer and Executive Director
BTG plc
1.0M GBP
Ian R. Garland Chief Executive Officer, Director and Member of Nominations & Corporate Governance Committee
Vernalis plc
610.0K GBP
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
John Dawson Chief Executive Officer and Director
Oxford BioMedica PLC
429.0K GBP
Erik Bogsch Chief Executive Officer, Managing Director, Member of Executive Board and Director
Chemical Works of Gedeon Richter Plc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STADA ARZNEIMITTEL AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.